| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81406 |
|
2,971 |
2,666 |
$2.86M |
| 81407 |
|
2,399 |
2,256 |
$1.88M |
| 81443 |
|
908 |
878 |
$1.83M |
| 81432 |
|
2,675 |
2,400 |
$1.80M |
| 81203 |
|
2,586 |
2,335 |
$598K |
| 81408 |
|
340 |
324 |
$416K |
| 81162 |
|
295 |
284 |
$416K |
| 81319 |
|
2,618 |
2,362 |
$382K |
| 81317 |
|
573 |
561 |
$146K |
| 81435 |
|
294 |
284 |
$133K |
| 81404 |
|
714 |
680 |
$98K |
| 81405 |
|
302 |
288 |
$65K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
723 |
436 |
$45K |
| 81403 |
|
713 |
680 |
$36K |
| 81439 |
|
23 |
22 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
414 |
307 |
$13K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
727 |
426 |
$12K |
| 81238 |
|
22 |
20 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
410 |
232 |
$6K |
| 81286 |
|
22 |
20 |
$5K |
| 81184 |
|
22 |
20 |
$2K |
| 81201 |
|
282 |
279 |
$780.00 |
| 81479 |
Unlisted molecular pathology procedure |
2,136 |
1,887 |
$447.32 |
| 81292 |
|
125 |
125 |
$0.00 |